Literature DB >> 27752876

Correspondence on the article: "Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up".

Nasir Ali1, Ahmed Nadeem Abbasi1, Muhammad Atif Mansha2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27752876     DOI： 10.1007/s12032-016-0847-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


× No keyword cloud information.
  4 in total

1.  [Outcome of cervical carcinoma with locoregional lymph node involvement by FDG-PET].

Authors:  A Paumier; P Blanchard; R Mazeron; I Dumas; P Morice; C Lhomme; S Leboulleux; C Haie-Meder
Journal:  Cancer Radiother       Date:  2012-03-02       Impact factor: 1.018

2.  Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.

Authors:  Alfonso Dueñas-González; Juan J Zarbá; Firuza Patel; Juan C Alcedo; Semir Beslija; Luis Casanova; Pittayapoom Pattaranutaporn; Shahid Hameed; Julie M Blair; Helen Barraclough; Mauro Orlando
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

3.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

Authors:  Elizabeth A Kidd; Barry A Siegel; Farrokh Dehdashti; Janet S Rader; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

4.  Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up.

Authors:  Daniela Luvero; Francesco Plotti; Alessia Aloisi; Stella Capriglione; Roberto Ricciardi; Andrea Miranda; Salvatore Lopez; Giuseppe Scaletta; Giovanna De Luca; Pierluigi Benedetti-Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2016-08-30       Impact factor: 3.064
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.